Dipeptidyl peptidase-4 inhibitors do not alter GH/IGF-I axis in adult diabetic patients.
Teti C, Talco M, Albertelli M, Albanese V, Minuto M, Aglialoro A, Monachesi M, Viviani G, Gatto F, Ferone D, Boschetti M.
Teti C, et al. Among authors: monachesi m.
J Endocrinol Invest. 2020 Mar;43(3):389-393. doi: 10.1007/s40618-019-01106-6. Epub 2019 Aug 31.
J Endocrinol Invest. 2020.
PMID: 31473983